These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Double-blind comparison of standard Sinemet and Sinemet CR in patients with mild-to-moderate Parkinson's disease. Feldman RG; Mosbach PA; Kelly MR; Thomas CA; Saint Hilaire MH Neurology; 1989 Nov; 39(11 Suppl 2):96-101; discussion 105. PubMed ID: 2685655 [TBL] [Abstract][Full Text] [Related]
5. Treating motor fluctuations with controlled-release levodopa preparations. Koller WC; Pahwa R Neurology; 1994 Jul; 44(7 Suppl 6):S23-8. PubMed ID: 8047257 [TBL] [Abstract][Full Text] [Related]
6. Controlled-release carbidopa-levodopa (Sinemet) in combination with standard Sinemet in advanced Parkinson's disease. Mark MH; Sage JI Ann Clin Lab Sci; 1989; 19(2):101-6. PubMed ID: 2665626 [TBL] [Abstract][Full Text] [Related]
7. Comparison of Sinemet CR4 and standard Sinemet: double blind and long-term open trial in parkinsonian patients with fluctuations. Jankovic J; Schwartz K; Vander Linden C Mov Disord; 1989; 4(4):303-9. PubMed ID: 2682215 [TBL] [Abstract][Full Text] [Related]
12. Treatment of early Parkinson's disease with controlled-release levodopa preparations. Rinne UK; Rinne JO Neurology; 1989 Nov; 39(11 Suppl 2):78-81; discussion 95. PubMed ID: 2586766 [TBL] [Abstract][Full Text] [Related]
13. Long-acting carbidopa-levodopa in the management of moderate and advanced Parkinson's disease. Hutton JT; Morris JL Neurology; 1992 Jan; 42(1 Suppl 1):51-6; discussion 57-60. PubMed ID: 1549202 [TBL] [Abstract][Full Text] [Related]
14. Open study of sustained-release formulation of levodopa and benserazide in parkinsonian patients. Kostić VS; Covicković-Sternić N Neurologija; 1990; 39(2):99-105. PubMed ID: 2267052 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and bioavailability of Sinemet CR: a summary of human studies. Yeh KC; August TF; Bush DF; Lasseter KC; Musson DG; Schwartz S; Smith ME; Titus DC Neurology; 1989 Nov; 39(11 Suppl 2):25-38. PubMed ID: 2685649 [TBL] [Abstract][Full Text] [Related]
16. Sinemet CR in the treatment of patients with Parkinson's disease already on long-term treatment with levodopa. Aarli JA; Gilhus NE Neurology; 1989 Nov; 39(11 Suppl 2):82-5; discussion 95. PubMed ID: 2586767 [TBL] [Abstract][Full Text] [Related]
17. Controlled release levodopa in Parkinson's disease: influence of selection criteria and conversion recommendations in the clinical outcome of 450 patients. STAR Study Group. Linazasoro G; Grandas F; Martínez Martín P; Bravo JL Clin Neuropharmacol; 1999; 22(2):74-9. PubMed ID: 10202601 [TBL] [Abstract][Full Text] [Related]
19. Development and progression of motor fluctuations and side effects in Parkinson's disease: comparison of Sinemet CR versus carbidopa/levodopa. Goetz CG; Tanner CM; Gilley DW; Klawans HL Neurology; 1989 Nov; 39(11 Suppl 2):63-6; discussion 72-3. PubMed ID: 2586764 [TBL] [Abstract][Full Text] [Related]
20. An open multicenter long-term treatment evaluation of Sinemet CR. Sinemet CR Multicenter Study Group. Bush DF; Liss CL; Morton A Neurology; 1989 Nov; 39(11 Suppl 2):101-4; discussion 105. PubMed ID: 2685646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]